Legend/Janssen CAR-T Immunotherapy to Start US Trial in Myeloma

Life Science

Link Health In-licenses China Rights to Lidocaine Patch

Life Science

WuXi Biologics and Tsinghua University Innovation Center for Immune Therapy Sign MOU and Announce Strategic Partnership

Life Science

China’s Cfmoto to Buy Into Austrian Moto-Maker KTM for Foothold in Europe

Technology

JHL Biotech Raises $106 Million in Pre-IPO Funding

Life Science

Alibaba Sells Online Pharmacy Unit to Ali Health for $1.4 Billion

Life Science

China’s Tencent, Korea Tourism Organization Partner to Boost Chinese Outbound Tourism

Technology

U.S. and China clash over ‘technology transfer’ at WTO

Technology

Luye Pharma Acquires AstraZeneca’s Signature Products Seroquel and Seroquel XR

Life Science

HitGen Closes $39 Million B Round for Drug Discovery/Development

Life Science

Teva hopes to launch migraine drug as soon as September

Life Science

Shanghai Pharma Extends Research Collaboration with Bracco Imaging

Life Science

WuXi Biologics Invests $60 Million in Another New Plant — In Singapore This Time

Life Science

Bioasis and WuXi Biologics Announce Initial Strategic Collaboration for the Development and Manufacturing of xB3-001, the Company’s Lead Investigational Candidate to Treat Brain Cancer

Life Science

Ahead of the Takeda-Shire Takeover, Takeda Selling Chinese Joint Venture

Life Science